Vivanza Biosciences Limited

BSE: 530057
Vivanza Biosciences Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
CIN L24105GJ1982PLC005057 Incorporated 06 March 1982 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - BSE: 530057 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹115.91 Cr
▲ 1461.44% YoY
Computed EBITDA · FY 2026
₹84.45 Lakh
▲ 381.22% YoY
Net profit · FY 2026
₹39.43 Lakh
▲ 158.49% YoY
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹3 Cr
Secured borrowings
Company age
44 yrs
Est. 1982
Last financials
Mar 2025
Balance sheet date

About Vivanza Biosciences Limited

Data last updated: 14 July 2026

Vivanza Biosciences Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 06 March 1982, the company has been in operation for over 44 years.

Registered with ROC Ahmedabad under CIN L24105GJ1982PLC005057. Listed on BSE: 530057.

Capital: an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. Formerly known as Ivee Injectaa Private Limited and Ivee Injectaa Limited. It is led by directors including Rina Kumari and Jayendra Mehta.

Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: 403 Sarthik 2 Opp. Rajpath Club S. G. Highway, Ahmedabad, Gujarat, India – 380054.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹115.91 Cr, reflecting significant growth compared to the previous year. The net worth stands at ₹4.36 Cr (up 9.95% YoY). Total assets are valued at ₹22.09 Cr (up 34.24% YoY).

The company is associated with 1 brand - Vivanza Biosciences. As per MCA filings, the company has open charges of ₹3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivanzabiosciences.com.

Company Details of Vivanza Biosciences Limited
CIN L24105GJ1982PLC005057
Registration Number 005057
Incorporation Date 06 March 1982
ROC Ahmedabad
Listing Status Listed (BSE: 530057)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Jayendra Mehta Managing Director Rina Kumari Director Sarang Bharat Pathak Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    403 Sarthik 2 Opp. Rajpath Club S. G. Highway, Ahmedabad, Gujarat, India – 380054
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Vivanza Biosciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vivanza Biosciences Limited report

Financials, compliance, directors, charges, ownership and filings for Vivanza Biosciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Vivanza Biosciences Limited

Vivanza Biosciences Limited has undergone 2 name changes throughout its history. The company was previously known as Ivee Injectaa Private Limited, and Ivee Injectaa Limited. The current legal name is Vivanza Biosciences Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Vivanza Biosciences Limited Current
Ivee Injectaa Private Limited Previous
Ivee Injectaa Limited Previous

CIN History of Vivanza Biosciences Limited

Vivanza Biosciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24105GJ1982PLC005057, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24105GJ1982PLC005057 Current
L24110GJ1982PLC005057 Previous
U24110GJ1982PTC005057 Previous

Associated Brands with Vivanza Biosciences Limited

Vivanza Biosciences Limited operates one associated brand: Vivanza Biosciences. These brands represent Vivanza Biosciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Vivanza Biosciences
Pharmaceutical products and medical gloves are manufactured in India. vivanzabiosciences.com

Business Activity of Vivanza Biosciences Limited

Vivanza Biosciences Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Vivanza Biosciences Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Vivanza Biosciences Limited

Vivanza Biosciences Limited is currently managed by 4 directors, with 23 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rina Kumari
Also directs: Vivanza Biosciences Limited, Hemo Organic Limited, Sampati Securities Limited and 1 more
Director 30 Apr 2024 2 Years 3 Months Current
Jayendra Mehta
Also directs: Vivanza Biosciences Limited, Vitaaglobal Bioscience Private Limited, Vaishali Lifecare Private Limited and 2 more
Managing Director 25 Apr 2023 3 Years 3 Months Current
Sarang Bharat Pathak
Also directs: Vivanza Biosciences Limited, Vivanza Lifesciences Private Limited, Virtual To Visual Jewellery Designs Private Limited
Director 30 Aug 2025 0 Years 11 Months Current
Hitesh Pradeep Rijwani
Also directs: Vivanza Biosciences Limited
Director 12 May 2025 1 Years 3 Months Current
View all directors

Financials of Vivanza Biosciences Limited FY 2026 filings available

Vivanza Biosciences Limited reported revenue of ₹115.91 Cr (up 1461.44% YoY) for FY 2026.

Revenue · FY 2026
₹115.91 Cr ▲ 1461.44%
Profit · FY 2026
₹39.43 Lakh ▲ 158.49%
Computed EBITDA · FY 2026
₹84.45 Lakh ▲ 381.22%
Revenue₹ Cr · Consolidated050100150FY 2019: ₹3 Cr2.7FY 2019FY 2020: ₹10 Cr · +261.8% YoY9.6+261.8%FY 2020FY 2021: ₹10 Cr · +2.8% YoY9.9+2.8%FY 2021FY 2022: ₹10 Cr · +5.2% YoY10.4+5.2%FY 2022FY 2023: ₹18 Cr · +71.2% YoY17.8+71.2%FY 2023FY 2024: ₹28 Cr · +56.3% YoY27.8+56.3%FY 2024FY 2025: ₹7 Cr · -73.3% YoY7.4-73.3%FY 2025FY 2026: ₹116 Cr · +1461.4% YoY116+1461.4%FY 2026
Net Profit₹ Cr · Consolidated-0.8-0.5-0.300.30.50.8FY 2019: ₹0 Cr (loss)-0.4FY 2019FY 2020: ₹0 Cr (loss) · +53.4% YoY-0.2FY 2020FY 2021: ₹0 Cr · +136.2% YoY0.1+136.2%FY 2021FY 2022: ₹0 Cr · +346.8% YoY0.3+346.8%FY 2022FY 2023: ₹1 Cr · +79.7% YoY0.6+79.7%FY 2023FY 2024: ₹1 Cr · -8.5% YoY0.5-8.5%FY 2024FY 2025: ₹1 Cr (loss) · -223.1% YoY-0.7FY 2025FY 2026: ₹0 Cr · +158.5% YoY0.4+158.5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0204060Q1'25: ₹2 Cr2.4Q1'25Q2'25: ₹3 Cr3Q2'25Q3'25: ₹2 Cr1.5Q3'25Q4'25: ₹0 Cr0.5Q4'25Q1'26: ₹9 Cr · +266.5% YoY8.9+266.5%Q1'26Q2'26: ₹55 Cr · +1744.9% YoY55.4+1744.9%Q2'26Q3'26: ₹45 Cr · +2915.7% YoY45.3+2915.7%Q3'26Q4'26: ₹6 Cr · +1217.4% YoY6.4+1217.4%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹115.91 Cr ₹7.42 Cr ₹27.84 Cr ₹17.81 Cr ₹10.4 Cr ₹9.89 Cr ₹9.62 Cr ₹2.66 Cr
Other Income ₹11.15 Lakh ₹6.15 Lakh ₹5.42 Lakh ₹47.54 Lakh ₹82.88 Lakh ₹50.56 Lakh ₹57.04 Lakh ₹0
Total Income ₹116.02 Cr ₹7.48 Cr ₹27.89 Cr ₹18.28 Cr ₹11.23 Cr ₹10.39 Cr ₹10.19 Cr ₹2.66 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹115.71 Cr ₹7.08 Cr ₹25.48 Cr ₹16.55 Cr ₹11.43 Cr ₹8.84 Cr ₹8.26 Cr ₹2.08 Cr
Changes in Inventories -₹1.29 Cr -₹25.68 Lakh ₹46.83 Lakh -₹4.65 Lakh -₹1.77 Cr ₹31.38 Lakh ₹1.04 Cr ₹27.87 Lakh
Employee Benefit Expense ₹49.24 Lakh ₹57.51 Lakh ₹45.13 Lakh ₹35.08 Lakh ₹29.62 Lakh ₹33.91 Lakh ₹29.81 Lakh ₹13.9 Lakh
Finance Costs ₹27.92 Lakh ₹35.14 Lakh ₹41.3 Lakh ₹41.86 Lakh ₹40.56 Lakh ₹46.76 Lakh ₹43.51 Lakh ₹41.85 Lakh
Depreciation & Amortisation ₹2.16 Lakh ₹1.4 Lakh ₹1.21 Lakh ₹26,000 ₹74,000 ₹98,000 ₹0 ₹0
Other Expenses ₹25.91 Lakh ₹38.94 Lakh ₹36.7 Lakh ₹28.76 Lakh ₹53.29 Lakh ₹30.09 Lakh ₹37.15 Lakh ₹18.5 Lakh
Total Expenses ₹115.48 Cr ₹8.15 Cr ₹27.19 Cr ₹17.57 Cr ₹10.9 Cr ₹10.27 Cr ₹10.4 Cr ₹3.1 Cr
Profit Before Exceptional Items & Tax ₹54.37 Lakh -₹66.57 Lakh ₹69.53 Lakh ₹71.65 Lakh ₹33.34 Lakh ₹12.34 Lakh -₹20.56 Lakh -₹44.09 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹54.37 Lakh -₹66.57 Lakh ₹69.53 Lakh ₹71.65 Lakh ₹33.34 Lakh ₹12.34 Lakh -₹20.56 Lakh -₹44.09 Lakh
Total Tax Expense ₹14.94 Lakh ₹84,000 ₹14.79 Lakh ₹11.81 Lakh ₹4,000 ₹4.89 Lakh ₹0 ₹0
Net Profit ₹39.43 Lakh -₹67.41 Lakh ₹54.74 Lakh ₹59.84 Lakh ₹33.3 Lakh ₹7.45 Lakh -₹20.56 Lakh -₹44.09 Lakh
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 - ₹0 -₹44.09 Lakh
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 - ₹0 ₹0
Other Comprehensive Income ₹0 -₹67.41 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹39.43 Lakh -₹1.35 Cr ₹54.74 Lakh ₹59.84 Lakh ₹33.3 Lakh ₹7.45 Lakh -₹20.56 Lakh -₹44.09 Lakh
EBITDA (computed) ₹84.45 Lakh -₹30.03 Lakh ₹1.12 Cr ₹1.14 Cr ₹74.64 Lakh ₹60.08 Lakh ₹22.95 Lakh -₹2.24 Lakh
Basic EPS ₹0.10 ₹-0.17 ₹0.14 ₹1.50 ₹0.83 ₹0.19 ₹-0.51 ₹-1.10
Diluted EPS ₹0.10 ₹-0.17 ₹0.14 ₹1.50 ₹0.83 ₹0.19 ₹-0.51 ₹-1.10
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹22.09 Cr ₹16.45 Cr ₹19.5 Cr ₹22.48 Cr ₹12.83 Cr ₹8.45 Cr ₹12.36 Cr ₹10.56 Cr
Non-current Assets ₹3.03 Cr ₹4.07 Cr ₹3.76 Cr ₹2.92 Cr ₹3.11 Cr ₹3.43 Cr ₹3.22 Cr ₹3.45 Cr
Current Assets ₹19.05 Cr ₹12.38 Cr ₹15.74 Cr ₹19.55 Cr ₹9.72 Cr ₹5.01 Cr ₹9.14 Cr ₹7.11 Cr
Property, Plant & Equipment ₹80.13 Lakh ₹69.88 Lakh ₹70.49 Lakh ₹67.95 Lakh ₹68.21 Lakh ₹68.95 Lakh ₹67.82 Lakh ₹67.82 Lakh
Inventories ₹3.55 Cr ₹2.26 Cr ₹2.01 Cr ₹2.47 Cr ₹2.43 Cr ₹65.35 Lakh ₹96.74 Lakh ₹2 Cr
Trade Receivables ₹12.38 Cr ₹8.06 Cr ₹11.54 Cr ₹12.48 Cr ₹7.84 Cr ₹6.25 Cr ₹6.54 Cr ₹5.15 Cr
Cash & Equivalents ₹6.53 Lakh ₹11.69 Lakh ₹16.69 Lakh ₹14.09 Lakh -₹2.68 Cr -₹3.09 Cr -₹2.78 Cr -₹3 Cr
Equity (Net Worth) ₹4.36 Cr ₹3.96 Cr ₹4.64 Cr ₹4.09 Cr ₹3.49 Cr ₹3.16 Cr ₹3.08 Cr ₹3.29 Cr
Equity Share Capital ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr
Borrowings (Non-current) ₹87.72 Lakh ₹3.33 Cr ₹2.68 Cr ₹1.43 Cr ₹2.6 Cr ₹0 ₹21.27 Lakh ₹57.97 Lakh
Borrowings (Current) ₹9.31 Cr ₹5.32 Cr ₹2.49 Cr ₹6.56 Cr ₹17.53 Lakh ₹35.75 Lakh ₹17.53 Lakh ₹90.26 Lakh
Total Debt (computed) ₹10.19 Cr ₹8.65 Cr ₹5.17 Cr ₹8 Cr ₹2.77 Cr ₹35.75 Lakh ₹38.8 Lakh ₹1.48 Cr
Current Liabilities ₹16.85 Cr ₹9.15 Cr ₹12.18 Cr ₹16.95 Cr ₹6.74 Cr ₹5.29 Cr ₹9.06 Cr ₹6.69 Cr
Total Liabilities ₹17.73 Cr ₹12.49 Cr ₹14.86 Cr ₹18.39 Cr ₹9.33 Cr ₹5.29 Cr ₹9.27 Cr ₹7.27 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹1.26 Cr -₹2.5 Cr ₹2.04 Cr -₹94.57 Lakh ₹2.47 Cr
Investing Cash Flow -₹5.21 Lakh -₹79,000 -₹3.75 Lakh ₹0 ₹0
Financing Cash Flow ₹1.26 Cr ₹2.46 Cr -₹1.98 Cr ₹1.03 Cr -₹2.06 Cr
Capital Expenditure ₹12.4 Lakh ₹79,000 ₹3.75 Lakh ₹0 ₹0
Free Cash Flow (computed) -₹1.38 Cr -₹2.51 Cr ₹2.01 Cr -₹94.57 Lakh ₹2.47 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹5.16 Lakh -₹4.99 Lakh ₹2.59 Lakh ₹8.58 Lakh ₹41.15 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹6.36 Cr ₹45.25 Cr ₹55.36 Cr ₹8.94 Cr ₹48.3 Lakh ₹1.5 Cr ₹3 Cr ₹2.44 Cr
Other Income ₹86,000 ₹7.79 Lakh ₹76,000 ₹1.74 Lakh ₹4.61 Lakh ₹1.03 Lakh ₹19,000 ₹32,000
Total Income ₹6.37 Cr ₹45.33 Cr ₹55.37 Cr ₹8.96 Cr ₹52.91 Lakh ₹1.51 Cr ₹3 Cr ₹2.44 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹5.96 Cr ₹44.15 Cr ₹55.99 Cr ₹9.61 Cr ₹47.79 Lakh ₹1.47 Cr ₹2.82 Cr ₹2.3 Cr
Changes in Inventories ₹56.01 Lakh ₹76.43 Lakh -₹1.56 Cr -₹1.06 Cr ₹69.56 Lakh -₹36.43 Lakh -₹11.03 Lakh -₹47.91 Lakh
Employee Benefit Expense ₹6.74 Lakh ₹4.04 Lakh ₹24.82 Lakh ₹13.64 Lakh ₹15.23 Lakh ₹13.29 Lakh ₹13.73 Lakh ₹15.26 Lakh
Finance Costs ₹6.58 Lakh ₹8.97 Lakh ₹4.71 Lakh ₹7.66 Lakh ₹7.98 Lakh ₹8.72 Lakh ₹9.15 Lakh ₹9.29 Lakh
Depreciation & Amortisation ₹1.1 Lakh ₹35,000 ₹35,000 ₹35,000 ₹28,000 ₹41,000 ₹41,000 ₹30,000
Other Expenses ₹93,000 ₹8.78 Lakh ₹6.64 Lakh ₹9.57 Lakh ₹11.04 Lakh ₹13.49 Lakh ₹4.01 Lakh ₹10.46 Lakh
Total Expenses ₹6.67 Cr ₹45.13 Cr ₹54.8 Cr ₹8.87 Cr ₹1.52 Cr ₹1.47 Cr ₹2.99 Cr ₹2.18 Cr
Profit Before Exceptional Items & Tax -₹30.14 Lakh ₹19.54 Lakh ₹56.29 Lakh ₹8.69 Lakh -₹98.97 Lakh ₹4.34 Lakh ₹1.55 Lakh ₹26.58 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹30.14 Lakh ₹19.54 Lakh ₹56.29 Lakh ₹8.69 Lakh -₹98.97 Lakh ₹4.34 Lakh ₹1.55 Lakh ₹26.58 Lakh
Total Tax Expense ₹14.94 Lakh ₹0 ₹0 ₹0 ₹84,000 ₹0 ₹0 ₹0
Net Profit -₹45.08 Lakh ₹19.54 Lakh ₹56.29 Lakh ₹8.69 Lakh -₹99.81 Lakh ₹4.34 Lakh ₹1.55 Lakh ₹26.58 Lakh
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 - - -
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 - - -
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 -₹99.81 Lakh ₹0 ₹0 ₹0
Total Comprehensive Income -₹45.08 Lakh ₹19.54 Lakh ₹56.29 Lakh ₹8.69 Lakh -₹2 Cr ₹4.34 Lakh ₹1.55 Lakh ₹26.58 Lakh
EBITDA (computed) -₹22.46 Lakh ₹28.86 Lakh ₹61.35 Lakh ₹16.7 Lakh -₹90.71 Lakh ₹13.47 Lakh ₹11.11 Lakh ₹36.17 Lakh
Basic EPS ₹-0.11 ₹0.05 ₹0.14 ₹0.02 ₹-0.25 ₹0.01 ₹0.00 ₹0.07
Diluted EPS ₹-0.11 ₹0.05 ₹0.14 ₹0.02 ₹-0.25 ₹0.01 ₹0.00 ₹0.07
Latest 8 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹112.23 Cr ₹2.94 Cr ₹14.41 Cr ₹14.21 Cr ₹9.15 Cr ₹9.22 Cr ₹9.43 Cr ₹2.22 Cr
Other Income ₹10.94 Lakh ₹3.46 Lakh ₹5.42 Lakh ₹38.68 Lakh ₹82.81 Lakh ₹49.98 Lakh ₹53.35 Lakh ₹0
Total Income ₹112.34 Cr ₹2.98 Cr ₹14.47 Cr ₹14.59 Cr ₹9.98 Cr ₹9.72 Cr ₹9.96 Cr ₹2.22 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹112.07 Cr ₹2.67 Cr ₹13.17 Cr ₹12.34 Cr ₹10.31 Cr ₹8.11 Cr ₹8.08 Cr ₹1.61 Cr
Changes in Inventories -₹1.1 Cr -₹4.29 Lakh -₹18.95 Lakh ₹61.52 Lakh -₹1.83 Cr ₹45.66 Lakh ₹1.06 Cr ₹37.24 Lakh
Employee Benefit Expense ₹33.08 Lakh ₹36.73 Lakh ₹30.62 Lakh ₹26.19 Lakh ₹11.98 Lakh ₹29.08 Lakh ₹25.7 Lakh ₹10.58 Lakh
Finance Costs ₹27.92 Lakh ₹35.08 Lakh ₹41.3 Lakh ₹41.82 Lakh ₹40.56 Lakh ₹46.76 Lakh ₹43.51 Lakh ₹41.85 Lakh
Depreciation & Amortisation ₹2.16 Lakh ₹1.4 Lakh ₹1.21 Lakh ₹26,000 ₹74,000 ₹98,000 ₹0 ₹0
Other Expenses ₹22.27 Lakh ₹31.42 Lakh ₹32.27 Lakh ₹26.83 Lakh ₹49.73 Lakh ₹24.42 Lakh ₹33.91 Lakh ₹16.23 Lakh
Total Expenses ₹111.82 Cr ₹3.67 Cr ₹14.04 Cr ₹13.91 Cr ₹9.51 Cr ₹9.58 Cr ₹10.17 Cr ₹2.67 Cr
Profit Before Exceptional Items & Tax ₹51.78 Lakh -₹69.37 Lakh ₹42.9 Lakh ₹68.72 Lakh ₹46.41 Lakh ₹14.8 Lakh -₹20.38 Lakh -₹44.9 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹51.78 Lakh -₹69.37 Lakh ₹42.9 Lakh ₹68.72 Lakh ₹46.41 Lakh ₹14.8 Lakh -₹20.38 Lakh -₹44.9 Lakh
Total Tax Expense ₹14.29 Lakh ₹14,000 ₹11.15 Lakh ₹11.81 Lakh ₹4,000 ₹4.81 Lakh ₹0 ₹0
Net Profit ₹37.49 Lakh -₹69.51 Lakh ₹31.75 Lakh ₹56.91 Lakh ₹46.37 Lakh ₹9.99 Lakh -₹20.38 Lakh -₹44.9 Lakh
Other Comprehensive Income ₹0 -₹69.51 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹37.49 Lakh -₹1.39 Cr ₹31.75 Lakh ₹56.91 Lakh ₹46.37 Lakh ₹9.99 Lakh -₹20.38 Lakh -₹44.9 Lakh
EBITDA (computed) ₹81.86 Lakh -₹32.89 Lakh ₹85.41 Lakh ₹1.11 Cr ₹87.71 Lakh ₹62.54 Lakh ₹23.13 Lakh -₹3.05 Lakh
Basic EPS ₹0.09 ₹-0.17 ₹0.08 ₹1.42 ₹1.16 ₹0.25 ₹-0.51 ₹-1.12
Diluted EPS ₹0.09 ₹-0.17 ₹0.08 ₹1.42 ₹1.16 ₹0.25 ₹-0.51 ₹-1.12
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹18.23 Cr ₹13.91 Cr ₹16.87 Cr ₹20.44 Cr ₹11.47 Cr ₹7.93 Cr ₹12.28 Cr ₹10.29 Cr
Non-current Assets ₹2.63 Cr ₹2.53 Cr ₹2.54 Cr ₹2.51 Cr ₹2.51 Cr ₹2.52 Cr ₹2.51 Cr ₹2.51 Cr
Current Assets ₹15.59 Cr ₹11.38 Cr ₹14.33 Cr ₹17.93 Cr ₹8.96 Cr ₹5.41 Cr ₹9.77 Cr ₹7.78 Cr
Property, Plant & Equipment ₹12.31 Lakh ₹2.06 Lakh ₹2.67 Lakh ₹13,000 ₹38,000 ₹1.13 Lakh ₹0 ₹0
Inventories ₹2.95 Cr ₹1.84 Cr ₹1.8 Cr ₹1.61 Cr ₹2.23 Cr ₹39.77 Lakh ₹85.43 Lakh ₹1.91 Cr
Trade Receivables ₹10.66 Cr ₹7.39 Cr ₹10.37 Cr ₹12.18 Cr ₹7.35 Cr ₹6.11 Cr ₹6.41 Cr ₹4.99 Cr
Cash & Equivalents ₹1.78 Lakh ₹4.94 Lakh ₹9.05 Lakh ₹10.45 Lakh -₹2.72 Cr -₹3.11 Cr -₹2.81 Cr -₹3.03 Cr
Equity (Net Worth) ₹4.4 Cr ₹4.02 Cr ₹4.72 Cr ₹4.4 Cr ₹3.83 Cr ₹3.37 Cr ₹3.27 Cr ₹3.47 Cr
Equity Share Capital ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr
Borrowings (Non-current) ₹87.72 Lakh ₹77.53 Lakh ₹77.53 Lakh ₹0 ₹1.68 Cr ₹0 ₹0 ₹0
Borrowings (Current) ₹6.62 Cr ₹5.32 Cr ₹2.49 Cr ₹6.56 Cr ₹0 ₹17.53 Lakh ₹17.53 Lakh ₹90.26 Lakh
Total Debt (computed) ₹7.5 Cr ₹6.09 Cr ₹3.26 Cr ₹6.56 Cr ₹1.68 Cr ₹17.53 Lakh ₹17.53 Lakh ₹90.26 Lakh
Current Liabilities ₹12.95 Cr ₹9.12 Cr ₹11.38 Cr ₹16.04 Cr ₹0 ₹4.57 Cr ₹9.01 Cr ₹6.82 Cr
Total Liabilities ₹13.83 Cr ₹9.89 Cr ₹12.16 Cr ₹16.04 Cr ₹7.64 Cr ₹4.57 Cr ₹9.01 Cr ₹6.82 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹1.21 Cr -₹2.47 Cr ₹1.8 Cr ₹16.09 Lakh -₹67.72 Lakh
Investing Cash Flow ₹5.48 Lakh -₹79,000 -₹3.75 Lakh ₹0 ₹0
Financing Cash Flow ₹1.13 Cr ₹2.44 Cr -₹1.77 Cr -₹7.53 Lakh ₹1.07 Cr
Capital Expenditure ₹12.4 Lakh ₹0 ₹0 ₹0 ₹0
Free Cash Flow (computed) -₹1.34 Cr -₹2.47 Cr ₹1.8 Cr ₹16.09 Lakh -₹67.72 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹3.16 Lakh -₹4.11 Lakh -₹1.39 Lakh ₹8.56 Lakh -₹2.72 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹5.75 Cr ₹44.93 Cr ₹53.73 Cr ₹7.82 Cr ₹16.96 Lakh ₹76.21 Lakh ₹1.58 Cr ₹42.78 Lakh
Other Income ₹77,000 ₹7.67 Lakh ₹76,000 ₹1.74 Lakh ₹1.92 Lakh ₹1.03 Lakh ₹19,000 ₹32,000
Total Income ₹5.75 Cr ₹45.01 Cr ₹53.74 Cr ₹7.84 Cr ₹18.88 Lakh ₹77.24 Lakh ₹1.59 Cr ₹43.1 Lakh
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹5.34 Cr ₹43.87 Cr ₹55.16 Cr ₹7.71 Cr ₹17.18 Lakh ₹75.35 Lakh ₹1.42 Cr ₹32.13 Lakh
Changes in Inventories ₹42.38 Lakh ₹76.43 Lakh -₹2.13 Cr -₹15.63 Lakh ₹69.69 Lakh -₹29.05 Lakh -₹4.52 Lakh -₹40.41 Lakh
Employee Benefit Expense ₹3.84 Lakh ₹4.04 Lakh ₹15.98 Lakh ₹9.22 Lakh ₹11.25 Lakh ₹7.38 Lakh ₹8.74 Lakh ₹9.36 Lakh
Finance Costs ₹6.58 Lakh ₹8.97 Lakh ₹4.71 Lakh ₹7.66 Lakh ₹7.92 Lakh ₹8.72 Lakh ₹9.15 Lakh ₹9.29 Lakh
Depreciation & Amortisation ₹1.1 Lakh ₹35,000 ₹35,000 ₹35,000 ₹28,000 ₹41,000 ₹41,000 ₹30,000
Other Expenses ₹22,000 ₹8.53 Lakh ₹4.12 Lakh ₹9.4 Lakh ₹8.97 Lakh ₹10.57 Lakh ₹2.1 Lakh ₹9.78 Lakh
Total Expenses ₹5.88 Cr ₹44.85 Cr ₹53.28 Cr ₹7.82 Cr ₹1.15 Cr ₹73.38 Lakh ₹1.58 Cr ₹20.45 Lakh
Profit Before Exceptional Items & Tax -₹12.31 Lakh ₹16.05 Lakh ₹46.21 Lakh ₹1.85 Lakh -₹96.41 Lakh ₹3.86 Lakh ₹53,000 ₹22.65 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹12.31 Lakh ₹16.05 Lakh ₹46.21 Lakh ₹1.85 Lakh -₹96.41 Lakh ₹3.86 Lakh ₹53,000 ₹22.65 Lakh
Total Tax Expense ₹14.29 Lakh ₹0 ₹0 ₹0 ₹14,000 ₹0 ₹0 ₹0
Net Profit -₹26.6 Lakh ₹16.05 Lakh ₹46.21 Lakh ₹1.85 Lakh -₹96.55 Lakh ₹3.86 Lakh ₹53,000 ₹22.65 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 -₹96.54 Lakh ₹0 ₹0 ₹0
Total Comprehensive Income -₹26.6 Lakh ₹16.05 Lakh ₹46.21 Lakh ₹1.85 Lakh -₹1.93 Cr ₹3.86 Lakh ₹53,000 ₹22.65 Lakh
EBITDA (computed) -₹4.63 Lakh ₹25.37 Lakh ₹51.27 Lakh ₹9.86 Lakh -₹88.21 Lakh ₹12.99 Lakh ₹10.09 Lakh ₹32.24 Lakh
Basic EPS ₹-0.07 ₹0.04 ₹0.12 ₹0.01 ₹-0.24 ₹0.01 ₹0.00 ₹0.06
Diluted EPS ₹-0.07 ₹0.04 ₹0.12 ₹0.01 ₹-0.24 ₹0.01 ₹0.00 ₹0.06
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Vivanza Biosciences Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Charges & Borrowings of Vivanza Biosciences Limited

Open charges
₹3 Cr
Satisfied charges
₹0
Breakdown by lending institutions
State Bank of India₹3.00 Cr
Latest charge details
DateLenderAmountStatus
10 Jan 2017 State Bank of India ₹3 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Vivanza Biosciences Limited

View historical data on people associated with Vivanza Biosciences Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Vivanza Biosciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Vivanza Biosciences Limited

Premium access

GST registrations and filing compliance for Vivanza Biosciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Vivanza Biosciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Vivanza Biosciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vivanza Biosciences Limited

Premium access

MSME payment history for Vivanza Biosciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vivanza Biosciences Limited

Premium access

Corporate group structure for Vivanza Biosciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vivanza Biosciences Limited

Premium access

MCA filings and documents for Vivanza Biosciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Vivanza Biosciences Limited

Activity
25 Sep 2025
Vivanza Biosciences Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Directors
30 Aug 2025
Sarang Bharat Pathak was appointed as a Director on 30 Aug 2025 & has been associated with this company since 11 months 22 days.
Directors
12 May 2025
Hitesh Pradeep Rijwani was appointed as a Director on 12 May 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Vivanza Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
30 Apr 2024
Rina Kumari was appointed as a Director on 30 Apr 2024 & has been associated with this company since 2 years 3 months.
Directors
25 Apr 2023
Jayendra Mehta was appointed as a Managing Director on 25 Apr 2023 & has been associated with this company since 3 years 3 months.

Recent News on Vivanza Biosciences Limited

Frequently Asked Questions about Vivanza Biosciences Limited

Vivanza Biosciences Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 06 March 1982 (44+ years old) and is registered under CIN L24105GJ1982PLC005057. Listed on BSE: 530057.

Vivanza Biosciences Limited reported revenue of ₹115.91 Cr for FY 2026 (up 1461.44% YoY) based on consolidated BSE filings.

The current directors of Vivanza Biosciences Limited are:

The primary industry of Vivanza Biosciences Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Yes. Vivanza Biosciences Limited is listed on BSE with code 530057.

Vivanza Biosciences Limited can be reached at the registered office: 403 Sarthik 2 Opp. Rajpath Club S. G. Highway, Ahmedabad, Gujarat, India – 380054, or through the website vivanzabiosciences.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available